Actively Recruiting

All Genders
ID05755451

Natural History of SMA: Long Term Longitudinal Study and Development of a Registry

Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2023-03-06

1200

Participants Needed

5

Research Sites

N/A

Total Duration

On this page

Sponsors

F

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead Sponsor

U

University of Milan

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to understand spinal muscular atrophy (SMA) by collecting and analyzing detailed information from a large group of patients over time. The study is observational and involves both looking back at past data and gathering new data from several academic centers in Italy. It focuses on how the disease progresses in patients who have and have not received treatment, and seeks to identify factors that affect disease progression. The study uses a structured disease registry shared among five academic centers to collect high-quality data on patients with SMA. Researchers gather information on motor function, respiratory health, nutrition, care levels, hospitalizations, and adverse events. Clinical evaluators and data managers are trained to ensure consistent and reliable data collection across all centers. Participants will be followed longitudinally, with data collected retrospectively and prospectively for up to 15 years. Researchers will assess motor function as the primary outcome, along with respiratory function and nutrition as secondary outcomes. The study also tracks patterns of care, hospitalizations, and adverse events to provide a comprehensive view of SMA over time.

CONDITIONS

Brief Title

Natural History of SMA

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • All patients with spinal muscular atrophy (SMA)
Not Eligible

You will not qualify if you...

  • Currently enrolled in other clinical trials

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - Up to 15 years

Participants with spinal muscular atrophy (SMA) are observed over time to understand the natural progression of the disease and collect information on functional measures, supportive care, hospitalizations, and adverse events.

Trial Site Locations

Total: 5 locations

1

Istituto Gaslini

Genova, Italy

Actively Recruiting

2

Nemo Sud

Messina, Italy

Actively Recruiting

3

Centro Clinico nemo

Milan, Italy

Actively Recruiting

4

Ospedale Bambino gesu

Rome, Italy

Actively Recruiting

5

Policlinico gemelli

Rome, Italy

Actively Recruiting

Loading map...

Research Team

E

Eugenio Mercuri, MD

M

Marika Pane, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase IV Open-Label Study Evaluating the Effectiveness and...

Muscular Atrophy, Spinal

Actively Recruiting

16 locations

A Phase IV Open-Label Study Evaluating the Effectiveness and...

Muscular Atrophy, Spinal

Actively Recruiting

19 locations

An Open Label, Single Cohort Study to Assess How Nusinersen ...

Muscular Atrophy, Spinal

Actively Recruiting

19 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here